Nuclear medicine research continues to expand the usefulness of the discipline for disease diagnosis and therapy management. This most recent study from April 17, in the American Journal of Roentgenology showed it is possible to quantify the degeneration of dopaminergic nigrostriatal transporters in PD using striatal SBR derived from DAT SPECT with good correlation with the HY stage.